Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Using RCT to Increase Completion Rates of the Health Assessment Questionnaire.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03435484
Recruitment Status : Completed
First Posted : February 16, 2018
Last Update Posted : August 9, 2019
Sponsor:
Information provided by (Responsible Party):
NYU Langone Health

Brief Summary:
The proposed study aims to examine several iterations of instructions/reminders that patients receive for completing the Health Assessment Questionnaire (self-reported health outcomes) for their outpatient visit at NYU Langone Orthopedic Center. The goal is to increase the completion rates of patient-reported health outcomes.

Condition or disease Intervention/treatment Phase
Patient-reported Outcomes Other: Current Instructions Other: Additional Instructions Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 27263 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Using Rapid Cycle Randomized Controlled Trials to Increase Completion Rates of the Patient-Reported Health Assessment Questionnaire During Outpatient Visits at NYU Langone Orthopedic Center
Actual Study Start Date : February 7, 2018
Actual Primary Completion Date : May 31, 2019
Actual Study Completion Date : May 31, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Health Checkup

Arm Intervention/treatment
Active Comparator: Usual Care
Participants in this group will receive the current version of instructions (a verbal reminder) for completing the Health Assessment Questionnaire.
Other: Current Instructions
Participants will receive a verbal reminder to complete the Health Assessment Questionnaire from the intake personnel, as part of usual care.

Active Comparator: Additional Instructions
Participants in this group will be exposed to additional instructions that remind them to complete the Health Assessment Questionnaire.
Other: Additional Instructions
Intervention includes various iterations of instructions for completing the Health Assessment Questionnaire. Participants will receive these instructions in addition to the verbal reminder from the intake personnel (usual care).




Primary Outcome Measures :
  1. Questionnaire Completion Rate (number of times patients complete or partially complete the questionnaire). [ Time Frame: Duration of the study, up to 6 months. ]
    Completion rate data is routinely collected by the medical center.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All patients who are eligible to receive the Health Assessment Questionnaire in preparation for and during their outpatient visit to the NYU Langone Orthopedic Center.

Exclusion Criteria:

  • N/A

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03435484


Locations
Layout table for location information
United States, New York
New York University School of Medicine
New York, New York, United States, 10016
Sponsors and Collaborators
NYU Langone Health
Investigators
Layout table for investigator information
Principal Investigator: Leora Horwitz, MD, MHS NYU Langone Health

Layout table for additonal information
Responsible Party: NYU Langone Health
ClinicalTrials.gov Identifier: NCT03435484     History of Changes
Other Study ID Numbers: RCT PHA Optimization
First Posted: February 16, 2018    Key Record Dates
Last Update Posted: August 9, 2019
Last Verified: August 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No